Transcutaneous Electrical Nerve Stimulation for Tissues Perfusion
NCT ID: NCT04069871
Last Updated: 2020-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-10-15
2020-10-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TENS
trans-cutaneous electrical nerve stimulation.
• Patients assigned to the EMS group received daily EMS sessions of both lower extremities starting from the second day for 5days.
Control
Sham TENS
Patients in the control group will receive sham TENS.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
trans-cutaneous electrical nerve stimulation.
• Patients assigned to the EMS group received daily EMS sessions of both lower extremities starting from the second day for 5days.
Sham TENS
Patients in the control group will receive sham TENS.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult and both gender.
* Hemodynamic stability
Exclusion Criteria
* Diabetic patients
* Patients who receive vasoactive drugs
* Patients with varicose vein
* Systemic scoliosis
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mostafa Samy Abbas
associate professor of anesthesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut University hospital
Asyut, Asyut Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TENS
Identifier Type: -
Identifier Source: org_study_id